This charming evening began with a cocktail hour and silent auction. There were 75 items donated for the silent auction and these items alone brought in over $12,000 in support of the foundation. Dinner and dancing followed. During dinner, three of the 50 for 50 recipients spoke about their experience and how their lives had been changed. One of the recipients also talked about how they were able to drive safely since they had their surgery. The 50 for 50 was a celebration of Virginia Eye Consultant’s 50th anniversary where they provided 50 no cost eye surgeries to people in need living in the Hampton Roads region. A very touching video was shown about the 50 for 50 event. One of the 50 for 50 recipients concluded with “I have been blessed by the best”.
This extraordinary social event for sight-saving efforts in the Hampton Roads Community was a huge success in raising money in support of the foundation.
The Virginia Eye Foundation is a non-profit, 501(c)3 tax exempt charity dedicated to sight saving eye care for the under/non-insured residents of the Hampton Roads Region.
The Virginia Eye Foundation cordially invites you to attend The Inaugural Eye Ball, a fundraising gala in support of the Virginia Eye Foundation. The gala will be held on Saturday, October 12, 2013 at the Marriott Norfolk Waterside.
Last week, Virginia Eye Consultants celebrated our 50th Anniversary by providing 50 no-cost eye surgeries to people in need. We called it our “50-for-50.”
More than 250 nominations were submitted earlier this year. A selection committee of community leaders who have helped shape Virginia Eye Consultants made the difficult choices, and 50 were selected.
Last week, we finally got the chance to help these deserving members of our community, and it made for a very emotional day.
“There’s a huge cadre of working poor in our community who desperately need eye care to continue working, take care of their families and to survive,” said Dr. John Sheppard, a partner at Virginia Eye Consultants. “I was reminded of how important it is to have reasonable, functional vision to live life to the fullest and to be gainfully employed.”
Read Suffolk News-Herald reporter Tracy Agnew’s full story here.
Trabectome is a Minimally Invasive Glaucoma Surgery (MIGS) that works to help the body help itself. It’s a three-step process that takes approximately 30 minutes.
1. Incision- A tiny incision is made across the chamber of the affected eye.
2. Electro-surgical pulse- Diseased tissue is removed with an electrosurgical pulse.
3. Washout- They eye is washed out with saline to remove tissue debris.
If you know or believe you have glaucoma, schedule a consultation with one of our expert eye care physicians to discuss your options. Call Virginia Eye Consultants at 757-622-2200.
Stephen V. Scoper, M.D. was the guest speaker at the July 30, 2013 meeting of the Washington D.C. Ophthalmology Society. Dr. Scoper discussed his clinical experience with cataract surgery as well as the results of several multi-center clinical trials. Over 60 ophthalmologists attended this meeting resulting in a lengthy question and answer session concerning Dr. Scoper’s experience with performing over 2,000 cataract procedures a year.
The discussion was centered on the importance of topical steroids and topical nonsteroidals in caring for patients in the postoperative period. Specifically, the results of two multi-center clinical trials concerning a new nonsteroidal eye drop, Ilevro (Alcon), were discussed.
As expected Ilevro performs much better than the vehicle in the study resulting in 61% of patients having 0 cells and 0 flare after using Ilevero once a day for two weeks following cataract surgery. The placebo arm showed only 24% of patients having 0 cells and 0 flares at two weeks. Additionally, 84% of patients in the Ilevro arm had no ocular pain at two weeks while only 38% of the placebo arm had no pain at two weeks.
More importantly, a second study compared head-to-head the Ilevro once-a-day with the Nevanac three-times-a-day for two weeks. This was the largest clinical trial to date for an ophthalmic nonsteroidal eye drop involving more than 2,000 patients.
Dr. Scoper and Virginia Eye Consultants were pleased to participate in this multi-center clinical trial. The Ilevro once-a-day was shown to be non-inferior to the Nevanac three-times-a-day at two weeks. 65% of patients in the Ilevro arm showed 0 cell while 67% of patients in the Nevanac arm showed 0 cell. This showed the Ilevro is a very effective once-a-day drug decreasing pain and inflammation after cataract surgery. These results compared favorably to a separate clinical trial showing another nonsteroidal ophthalmic drop, Prolensa that showed 44.5% of patients with 0 cell flare at two weeks.
Dr. Scoper and Virginia Eye Consultants are pleased to be involved in the process of bringing new drugs to our patients by participating in multi-center clinical trials. Dr. Scoper and his associates at Virginia Eye Consultants speak nationally and internationally about the results of these trials.
A study performed at Virginia Eye Consultants shows that daily dietary supplementation with a unique combination of omega fatty acids (GLA, EPA and DHA) for six months is effective in improving ocular irritation symptoms and halting the progressions of moderate to severe dry eye.
The clinical trial was conducted at Virginia Eye Consultants and at Baylor College of Medicine. Thirty-eight post-menopausal women with tear dysfunction in both eyes were evaluated. Participants randomly received HydroEye® (a proprietary blend of omega fatty acids, antioxidants and other nutrients) or a placebo every day. HydroEye® was found to improve ocular irritation symptoms, suppress ocular surface inflammation, and maintain corneal surface smoothness.
“Achieving statistical significance in a dry eye study is a remarkable accomplishment, especially given the extreme difficulty that many highly regarded pharmaceutical companies have had in bringing a prescription dry eye product to market,” said John D. Sheppard, M.D., M.M.Sc., president, Virginia Eye Consultants, professor of ophthalmology, clinical director of the Lee Laboratory for Ocular Pharmacology at Eastern Virginia Medical School, and co-principal investigator who initiated this research project. “This was a prospective, randomized, multicenter, placebo-controlled trial as would be any U.S. Food & Drug Administration registration clinical study.”
Dry eye disease is a multi-factorial disease that affects an estimated 25 million people in the United States alone. It is often under-recognized and under-diagnosed. Moderate to severe dry eye can significantly deteriorate the quality of life for those who suffer from the condition.
A wide variety of dry eye treatments are available, however many have disadvantages or side effects. If you’re suffering from dry eye, call Virginia Eye Consultants at 757-622-2200. We offer a variety of advanced treatments.
Sources: Science Based Health
This is another exciting week for Virginia Eye Consultants! Dr. Sheppard and our clinical research team just completed the practice’s first corneal collagen cross-linking investigational treatment.
Congratulations to our clinical research team for a job well done in getting this trial up and running!
Corneal collagen cross-linking furthers Virginia Eye Consultants’ mission to provide world class specialty eye care by leaders in innovation and education, using state of the art technology.
With 50 years of experience providing top quality eye procedures to residents of Hampton Roads and beyond, we continue to grow in experience and service offerings.
July is National Dry Eye Awareness Month. Dry eye disease is a multi-factorial disease that affects an estimated 25 million people in the United States alone. It is often under-recognized and under-diagnosed.
One of the latest devices in dry eye technology is the TearLab Osmolarity System. By using the TearLab, Accredited Dry Eye Centers like Virginia Eye Consultants can quickly and painlessly measure a small sample of a patient’s tears to determine how dry they truly are. Your unique “tear number” will allow your doctor to decipher the best means of treatment for you.
Eighty-six percent of dry eye patients suffer from evaporative dry eye. The only FDA-cleared treatment for evaporative dry eye is LipiFlow®, which is available at Virginia Eye Consultants.
Evaporative dry eye disease is caused when blocked meibomian glands prevent the eyes from secreting enough oily lipids to maintain a comfortable tear consistency. LipiFlow® unblocks these oil glands, thus helping the eyes restore a healthy tear film.
If you’re experiencing symptoms of dry eye disease, such as dryness, soreness, burning, grittiness or eye fatigue, schedule a consultation with one of our expert eye care physicians to discuss your options. Call Virginia Eye Consultants at 757-622-2200.
PRK was the first type of laser eye surgery for vision correction. Although LASIK is much more popular now, PRK is still commonly performed and sometimes offers particular advantages for some patients.
Like LASIK, PRK uses an excimer laser to reshape the cornea. The main difference between PRK and LASIK is that LASIK surgery creates a flap in the cornea, while PRK removes the cornea’s entire outer layer.
The outcomes of PRK and LASIK are similar, but PRK has a slightly longer recovery time. The PRK recovery time is longer because it takes a few days to generate new cells that cover the surface of the eye, making patients slightly more at risk for infection and obscured vision. The vision improvement is more gradual with PRK and the final outcome may take several weeks to experience. LASIK patients generally feel less discomfort and experience clear vision much sooner.
PRK offers distinct benefits, though because the entire thickness of the “stroma” layer is available for treatment when the cornea’s outer layer is removed. If the patient’s cornea is too thin to create a corneal flap for LASIK, PRK is often the best option.
If you’re interested in learning more about PRK and LASIK, call Virginia Eye Consultants at 800-321-EYES (3937) to schedule your free consultation.